CLB
Overvalued by 98.6% based on the discounted cash flow analysis.
Market cap | $801.52 Million |
---|---|
Enterprise Value | $965.67 Million |
Dividend Yield | $0.04 (0.23%) |
Earnings per Share | $0.5 |
Beta | 0.75 |
Outstanding Shares | 46,899,863 |
Avg 30 Day Volume | 385,568 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 33.8 |
---|---|
PEG | -14.98 |
Price to Sales | 1.7 |
Price to Book Ratio | 4.25 |
Enterprise Value to Revenue | 1.92 |
Enterprise Value to EBIT | 20.84 |
Enterprise Value to Net Income | 40 |
Total Debt to Enterprise | 0.19 |
Debt to Equity | 0.92 |
No data
No data
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...